Harold D Stowe, BS
Harold “”Hal” Stowe is a Regulatory Consultant supporting clients achieve pre-market and ongoing compliance with US FDA and EPA federal regulation.
Hal supports both start-ups and multi-national companies in the development and execution of strategies to navigate FDA’s premarket authorization pathways for medical devices and combination products – including 510(k) Premarket Notification, De Novo Review, and Premarket Approval applications (PMA).
Hal assists clients with receiving FDA feedback on a variety of actions:
- Investigational Device Exemptions (IDE)
- Pre-Submissions
- 513(g) Requests
Hal also specializes in pre- and post-market compliance for chemical and mechanical antimicrobial technologies under the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA).
Hal has a Bachelor of Science in Economics, and Bachelor of Science in Agribusiness from Clemson University.